Daniel Bradbury

Affiliations

  • Director at Castle Biosciences Inc (CSTL), 2025-05-23
  • Executive Chairman at Equillium Inc. (EQ), 2025-02-20
  • Director at Vivani Medical Inc. (VANI), 2025-01-04
  • Director at Intercept Pharmaceuticals Inc. (ICPT), 2023-11-13
  • Director at Nuvation Bio Inc. (NUVB), 2021-02-27
  • Director at Geron Corp (GERN), 2019-04-01
  • Director at Corcept Therapeutics Inc (CORT), 2019-02-13
  • Director at Illumina Inc (ILMN), 2017-05-26
  • Director at Biomed Realty Trust Inc (BMR), 2016-01-29
  • Director at Biomed Realty L P (NONE), 2013-01-04
  • President & Chief Executive Of at Amylin Pharmaceuticals Inc (AMLN), 2012-08-10
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ICPT $64.00 7,812 $499,968.00 11,642 2018-04-09 Filing
CORT $1.83 13,925 $25,521.74 317,925 2014-05-12 Filing
CORT $1.79 125,000 $224,212.50 304,000 2014-05-09 Filing
GERN $1.75 142,776 $249,858.00 142,776 2014-05-09 Filing
CORT $1.40 99,000 $138,481.20 179,000 2012-11-23 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
CSTL $28.17 1,425 $40,146.53 0 2025-02-05 Filing
CSTL $28.17 1,425 $40,146.53 0 2025-02-05 Filing
CSTL $28.17 5,017 $141,343.94 0 2025-02-05 Filing
CSTL $29.82 134 $3,995.88 1,425 2025-01-06 Filing
CSTL $29.82 134 $3,995.88 1,425 2025-01-06 Filing